Invion Ltd (IVX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Invion Ltd (IVX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH140441D
  • |
  • Pages: 39
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Invion Ltd (Invion) is a life sciences company that develops products for the treatment of inflammatory diseases such as chronic inflammatory, airway disease and inflammation caused by autoimmune disease. The company's pipeline products include INV102 nadolol, a beta adrenergic biased ligand targeted to reverse mucous metaplasia in the airway epithelium for the treatment of chronic inflammatory airway diseases; INV103 ala-Cpn10, a naturally occuring human protein for the treatment of chronic inflammation; and INV104 zafirlukast, a leukotriene receptor antagonist for the prevention of asthma attacks. Invion also conducts clinical development programs for developing zafirlukast as a novel non-steroidal, anti-inflammatory treatment to prevent asthma attacks. The company has operations in Melbourne, Australia; and Delaware, the US. Invion is headquartered in Melbourne, Victoria, Australia.

Invion Ltd (IVX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Invion Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Invion Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Invion Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Invion Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Invion Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Invion Ltd, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Invion Enters into R&D Agreement with Hudson Institute of Medical 10

Invion Enters into Development and Licensing Agreement with Hovione 11

Invion Enters Into Co-Development Agreement With 3M Drug Delivery Systems For INV102 And INV104 12

Licensing Agreements 13

Chronic Airway Therapeutics to Receive Respiratory Assets from Invion 13

Invion Enters into Licensing Agreement with Cho Group 14

Invion Enters Into Licensing Agreement With Accolade For Zafirlukast 15

Equity Offering 17

Invion Raises USD19.46 Million in Rights Offering of Shares 17

Invion Raises USD0.5 Million in Private Placement of Ordinary Shares 18

Invion Raises USD0.4 Million in Private Placement of Shares 19

Invion to Raise USD15 Million in Private Placement of Shares 20

Invion Completes Rights Offering Of Shares For USD0.8 Million 21

Invion Completes Private Placement Of Shares For USD 4.5 Million 23

Invion Completes Private Placement Of Shares For USD 1.9 Million 24

Invion Completes Rights Offering Of Shares For USD 1 Million 25

Acquisition 27

CBio Completes Acquisition Of Inverseon, Clinical-Stage Pharma Company 27

Invion Ltd-Key Competitors 29

Invion Ltd-Key Employees 30

Invion Ltd-Locations And Subsidiaries 31

Head Office 31

Recent Developments 32

Financial Announcements 32

Aug 28, 2018: Invion-Highlights of appendix 4E and full year financial results 32

Corporate Communications 34

Mar 22, 2018: Change to Invion Board of Directors 34

Mar 21, 2018: Leading Ovarian Cancer Expert Dr Andrew Stephens Appointed to Invion's Advisory Board 35

Dec 01, 2017: Invion Appoints Mr Thian Chew As Director And Chairman 36

Government and Public Interest 37

Jul 05, 2018: Photosoft Efficiently Destroys Ovarian Cancer Cells In Vitro 37

Appendix 39

Methodology 39

About GlobalData 39

Contact Us 39

Disclaimer 39

List of Figures

Invion Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Invion Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Invion Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Invion Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Invion Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Invion Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Invion Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Invion Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

List of Tables

Invion Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Invion Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Invion Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Invion Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Invion Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Invion Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Invion Enters into R&D Agreement with Hudson Institute of Medical 10

Invion Enters into Development and Licensing Agreement with Hovione 11

Invion Enters Into Co-Development Agreement With 3M Drug Delivery Systems For INV102 And INV104 12

Chronic Airway Therapeutics to Receive Respiratory Assets from Invion 13

Invion Enters into Licensing Agreement with Cho Group 14

Invion Enters Into Licensing Agreement With Accolade For Zafirlukast 15

Invion Raises USD19.46 Million in Rights Offering of Shares 17

Invion Raises USD0.5 Million in Private Placement of Ordinary Shares 18

Invion Raises USD0.4 Million in Private Placement of Shares 19

Invion to Raise USD15 Million in Private Placement of Shares 20

Invion Completes Rights Offering Of Shares For USD0.8 Million 21

Invion Completes Private Placement Of Shares For USD 4.5 Million 23

Invion Completes Private Placement Of Shares For USD 1.9 Million 24

Invion Completes Rights Offering Of Shares For USD 1 Million 25

CBio Completes Acquisition Of Inverseon, Clinical-Stage Pharma Company 27

Invion Ltd, Key Competitors 29

Invion Ltd, Key Employees 30

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Invion Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17743
Site License
USD 500 INR 35485
Corporate User License
USD 750 INR 53228

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com